Video games tested as depression treatment in large study
NCT ID NCT05426265
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether playing specially designed video games (MEL-T01 and MEL-S01) for 12 weeks could reduce depression symptoms in adults with major depressive disorder. Over 1000 participants were assigned to either the game therapy or usual care. The main goal was to see if depression scores improved more with the games.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MEL-T01 and MEL-S01 (game-based digital therapy software devices)
- What this could lead to
- If it works, this could offer a new, engaging way to help ease depression symptoms without medication.
- What could go wrong
- This is a completed study, but results are not yet widely confirmed. The effect may be small or not better than usual care. Digital games may not work for everyone with depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,001 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Between 18-65 year-old * Suffering from major depressive disorder * Have an ongoing mental health treatment contact to basic healthcare, specialised healthcare, student healthcare or occupational healthcare * Has sufficient eyesight with or without prescription * Has a Windows computer with internet connection and mouse * Has email and phone number Exclusion Criteria: * They have threat of self-harm * They have addiction to digital games * They have psychotic disorders * They are pregnant or breastfeeding * They have impaired ability in decision making * They are prisoner or forensic subject * They have neurological disorders such as epilepsy or brain injury
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Major depressive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalto University (TMS)
Espoo, Uusimaa, 02150, Finland
-
Aalto University, Department of Neuroscience and Biomedical Engineering
Espoo, Uusimaa, 02150, Finland
-
Helsinki University Hospital BioMag laboratory
Helsinki, Uusimaa, 00029, Finland
-
Helsinki University Hospital, Psychiatry
Helsinki, Uusimaa, 00014, Finland
-
Turku University Hospital
Turku, Southwest Finland, 20521, Finland
-
University of Helsinki Neuroscience Center (MEG, MRI)
Helsinki, Uusimaa, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an antipsychotic restore feelings in people with depression?
- Can intense brain zaps lift depression? scientists track blood flow in real time
- Can an ancient herbal capsule boost antidepressant power?
- Can talk therapy keep Esketamine's relief going?
- Can brisk walking boost antidepressant results?
- Scientists probe brain's reward system in mental illness